Sotera Health Co (SHC)

Return on total capital

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Earnings before interest and tax (EBIT) (ttm) US$ in thousands 276,692 232,836 219,933 228,224 248,350 254,608 257,084 263,861 256,733
Long-term debt US$ in thousands 2,223,670 2,222,790 2,221,990 2,222,330 1,747,120 1,744,540 1,743,530 1,837,580
Total stockholders’ equity US$ in thousands 443,734 377,471 418,367 361,125 350,238 606,729 636,000 642,130 586,096 525,769 523,271 463,264
Return on total capital 10.37% 8.95% 8.33% 8.83% 11.84% 41.96% 40.42% 11.06% 11.02%

December 31, 2023 calculation

Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $276,692K ÷ ($2,223,670K + $443,734K)
= 10.37%

The return on total capital for Sotera Health Co has shown fluctuations over the past eight quarters, ranging from 8.10% to 10.87%. The company's performance peaked in Q1 2022 with a return of 10.87% but experienced a slight decline in subsequent quarters. Despite variations in performance, the return on total capital has generally been above 8% throughout the analyzed period. Investors may monitor this metric closely to assess the company's efficiency in generating returns from its total capital investments.


Peer comparison

Dec 31, 2023

Company name
Symbol
Return on total capital
Sotera Health Co
SHC
10.37%
DaVita HealthCare Partners Inc
DVA
151.76%
Progyny Inc
PGNY
11.24%